This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: The Innovative Work of Nanding Zhao in Alzheimer's Disease Research
Introduction
Nanding Zhao, a distinguished inventor based in Tokyo, Japan, has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of Alzheimer's disease. With a keen focus on the intersection of molecular biology and neurological disorders, Zhao's patent highlights his dedication to advancing healthcare solutions.
Latest Patents
Nanding Zhao holds a patent for "DNA and protein for the diagnosis and treatment of Alzheimer's disease." This groundbreaking invention involves a DNA sequence selected from 17 specific sequences that exhibit varied expression levels in Alzheimer's patients compared to those in a normal human brain. The patent outlines the use of this DNA, alongside corresponding polypeptides and antibodies, to facilitate the diagnosis and therapeutic treatment of Alzheimer's disease, offering promising avenues for future research and clinical applications.
Career Highlights
Zhao's career at Kyowa Hakko Kogyo Co., Ltd. has been marked by innovative research and development initiatives in the life sciences sector. His work not only exemplifies cutting-edge scientific inquiry but also underscores the importance of intellectual property in the medical research field.
Collaborations
Throughout his career, Nanding Zhao has collaborated with notable colleagues, including Tetsuro Kuga and Satoshi Nakagawa. These collaborations have enriched his research endeavors, fostering an environment of shared ideas and interdisciplinary approaches to solving complex medical challenges.
Conclusion
Nanding Zhao's innovative contributions to Alzheimer’s disease diagnosis and treatment reflect the vital role that inventors play in advancing healthcare. His patent not only signifies individual achievement but also highlights the collaborative spirit within research institutions, ultimately paving the way for improved patient outcomes in the future.
